
Varicella zoster virus infection due to Pfizer-BioNTech mRNA COVID-19 vaccine and sinovac vaccine in two relapsing-remitting multiple sclerosis patients during fingolimod therapy
Author(s) -
Turan Ömer Faruk,
Mesrure Köseoğlu,
Koc Emine Rabia
Publication year - 2022
Publication title -
neuroimmunology reports
Language(s) - English
Resource type - Journals
ISSN - 2667-257X
DOI - 10.1016/j.nerep.2022.100078
Subject(s) - fingolimod , medicine , virology , covid-19 , multiple sclerosis , immunology , virus , immune system , varicella zoster virus , disease , pathology , infectious disease (medical specialty)